Stephanie M. LaVergne

Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection

Stephanie M. LaVergne, Theron Hamilton, Biswajit Biswas et al. · Open Forum Infectious Diseases · 2018 · 238 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae

Stephanie M. LaVergne, Sophia Stromberg, Bridget A. Baxter et al. · BMC Infectious Diseases · 2021 · 61 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathology +17

Quality of Life (QoL) Is Reduced in Those with Severe COVID-19 Disease, Post-Acute Sequelae of COVID-19, and Hospitalization in United States Adults from Northern Colorado

Kim McFann, Bridget A. Baxter, Stephanie M. LaVergne et al. · International Journal of Environmental Research and Public Health · 2021 · 43 citations · Full text

Pharmacy, Infectious Diseases, Health Assessment +14

Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae

Stephanie M. LaVergne, Saori Sakabe, Lansana Kanneh et al. · The Journal of Infectious Diseases · 2020 · 22 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Expansion of CD8+ T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors

Stephanie M. LaVergne, Saori Sakabe, Mambu Momoh et al. · PLoS neglected tropical diseases · 2022 · 16 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17